Search Results - "Calderón, E. J."

Refine Results
  1. 1

    Efficacy assessment of an intramammary treatment with a new recrystallized enrofloxacin vs ceftiofur and parenteral enrofloxacin in dairy cows with nonsevere clinical mastitis by Viveros, M., Lopez‐Ordaz, R., Gutiérrez, L., Miranda‐Calderón, J. E., Sumano, H.

    “…A recrystallized form of enrofloxacin as dehydrate‐HCl (enro‐C) was assessed for bacteriological and clinical cure efficacies in Holstein‐Friesian cows…”
    Get full text
    Journal Article
  2. 2

    Characterization of physical interaction between Casiopeina III-ia and chitosan. Toward a Cas III-ia drug delivery system by Miranda-Calderón, J.E., Medina-Torres, L., Tinoco-Mendez, M., Moreno-Esparza, R., Ruiz-Ramirez, L., Gracia-Mora, J., Gracia-Mora, I., Bernad-Bernad, M.J.

    Published in Carbohydrate research (03-01-2011)
    “…Casiopeina III-ia is not breaking due to interactions with chitosan. Then, it maintains effectiveness against cancer cell line. Casiopeínas® are a new…”
    Get full text
    Journal Article
  3. 3

    Economic and Environmental Benefits of Dynamic Demand in Providing Frequency Regulation by Aunedi, Marko, Kountouriotis, P-Aristidis, Calderon, J. E. Ortega, Angeli, David, Strbac, Goran

    Published in IEEE transactions on smart grid (01-12-2013)
    “…Increase of penetration of intermittent renewable power connected to the system will increase the requirements for frequency regulation services. If these…”
    Get full text
    Journal Article
  4. 4

    Strategies of analgesic treatment after cesarean delivery. Current state and new alternatives by Arroyo-Fernández, F J, Calderón Seoane, J E, Torres Morera, L M

    “…The number of caesarean sections performed worldwide is increasing, and with it, the need for the optimal analgesia strategies. Deficient postoperative…”
    Get full text
    Journal Article
  5. 5

    Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers by Esteves, F., Calé, S.S., Badura, R., de Boer, M.G., Maltez, F., Calderón, E.J., van der Reijden, T.J., Márquez-Martín, E., Antunes, F., Matos, O.

    Published in Clinical microbiology and infection (01-04-2015)
    “…The diagnosis of Pneumocystis pneumonia (PCP) relies on microscopic visualization of Pneumocystis jirovecii organisms or DNA detection in pulmonary specimens…”
    Get full text
    Journal Article
  6. 6

    Microneedles as an Alternative Strategy for Drug Delivery by Morales-FLorido, Isabel Marlen, Miranda Calderon, Jorge Esteban, Gómez Sámano, Miguel Ángel, Escobar-Chavez, Jose Juan

    “…The transdermal route has been widely studied in the last decade due to its multiple advantages, where one of the most promising transdermal systems are…”
    Get full text
    Journal Article
  7. 7

    Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia by Esteves, F., de Sousa, B., Calderón, E.J., Huang, L., Badura, R., Maltez, F., Bassat, Q., de Armas, Y., Antunes, F., Matos, O.

    Published in Clinical microbiology and infection (01-06-2016)
    “…Pneumocystis jirovecii causes severe interstitial pneumonia (PcP) in immunosuppressed patients. This multicentre study assessed the distribution frequencies of…”
    Get full text
    Journal Article
  8. 8

    Effect of casiopein III-ia loaded into chitosan nanoparticles on tumor growth inhibition by Miranda-Calderón, J.E., Macías-Rosales, L., Gracia-Mora, I., Ruiz-Azuara, L., Faustino-Vega, A., Gracia-Mora, J., Bernad-Bernad, M.J.

    “…Casiopeins are a group of anticancer agents that are coordination complexes with copper as the metallic center. Cas III-ia has shown greater antineoplastic…”
    Get full text
    Journal Article
  9. 9

    Pneumocystis jiroveci Genotypes in the Spanish Population by Cano, M. A. Montes, de la Horra, C., Martín-Juan, J., Varela, J. M., Torronteras, R., Respaldiza, N., Medrano, F. J., Calderón, E. J.

    Published in Clinical infectious diseases (01-07-2004)
    “…This study describes the genotype distribution of Pneumocystis jiroveci in 79 respiratory samples obtained from 15 patients with acquired immunodeficiency…”
    Get full text
    Journal Article
  10. 10

    High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia by Lanaspa, M., O'Callaghan-Gordo, C., Machevo, S., Madrid, L., Nhampossa, T., Acácio, S., de la Horra, C., Friaza, V., Campano, E., Alonso, P.L., Calderón, E.J., Roca, A., Bassat, Q.

    Published in Clinical microbiology and infection (01-11-2015)
    “…We aimed to describe Pneumocystis jirovecii pneumonia (PCP) prevalence and features in children from sub-Saharan Africa and to investigate PCP-associated risk…”
    Get full text
    Journal Article
  11. 11

    Pneumocystis jirovecii colonisation in patients with interstitial lung disease by Vidal, S., de la Horra, C., Martín, J., Montes-Cano, M.A., Rodríguez, E., Respaldiza, N., Rodríguez, F., Varela, J.M., Medrano, F.J., Calderón, E.J.

    Published in Clinical microbiology and infection (01-03-2006)
    “…A prospective study was conducted to determine the prevalence of colonisation by Pneumocystis jirovecii in 80 consecutive patients who required bronchoscopy…”
    Get full text
    Journal Article
  12. 12

    Physicochemical characterization and pharmacokinetics in broiler chickens of a new recrystallized enrofloxacin hydrochloride dihydrate by Gutierrez, L., Miranda-Calderon, J. E., Garcia-Gutierrez, P., Sumano, H.

    “…Enrofloxacin, a key antimicrobial agent in commercial avian medicine, has limited bioavailability (60%). This prompted its chemical manipulation to yield a new…”
    Get full text
    Journal Article
  13. 13

    Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain by Esteves, F., Montes-Cano, M.A., Horra, C. de la, Costa, M.C., Calderón, E.J., Antunes, F., Matos, O.

    Published in Clinical microbiology and infection (01-04-2008)
    “…Pneumonia caused by the opportunistic organism Pneumocystis jirovecii is a clinically important infection affecting AIDS and other immunocompromised patients…”
    Get full text
    Journal Article
  14. 14

    Serum and bal beta- d -glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients by Salerno, D, Mushatt, D, Myers, L, Zhuang, Y, de la Rua, N, Calderon, E.J, Welsh, D.A

    Published in Respiratory medicine (01-11-2014)
    “…Background/purpose The diagnosis of patients with pulmonary infiltrates and human immunodeficiency virus (HIV) infection remains a challenge. In current…”
    Get full text
    Journal Article
  15. 15

    Pneumocystis jirovecii pneumonia in developing countries by De Armas Rodríguez, Y., Wissmann, G., Müller, A.L., Pederiva, M.A., Brum, M.C., Brackmann, R.L., Capó De Paz, V., Calderón, E.J.

    Published in Parasite (Paris) (01-08-2011)
    “…Pneumocystis pneumonia (PcP) is a serious fungal infection among immunocompromised patients. In developed countries, the epidemiology and clinical spectrum of…”
    Get full text
    Journal Article
  16. 16

    Pneumocystis jirovecii infection in patients with acute interstitial pneumonia by Martínez-Rísquez, M T, Friaza, V, de la Horra, C, Martín-Juan, J, Calderón, E J, Medrano, F J

    “…OBJECTIVEAcute interstitial pneumonia (AIP) is a severe disease of unknown etiology. Pneumocystis jirovecii is an atypical opportunistic fungus able to…”
    Get full text
    Journal Article
  17. 17

    Pneumocystis jirovecii colonization in chronic pulmonary disease by Gutiérrez, S., Respaldiza, N., Campano, E., Martínez-Risquez, M.T., Calderón, E.J., De La Horra, C.

    Published in Parasite (Paris) (01-05-2011)
    “…Pneumocystis jirovecii causes pneumonia in immunosuppressed individuals. However, it has been reported the detection of low levels of Pneumocystis DNA in…”
    Get full text
    Journal Article
  18. 18

    Epidemiology of Pneumocystis infection in Human by CALDERON, E. J

    Published in Journal de mycologie médicale (01-12-2009)
    “…Pneumocystis jirovecii ( P.  jirovecii) is an atypical fungus that causes pneumonia in immunosuppressed individuals and significant questions about its…”
    Get full text
    Journal Article Conference Proceeding
  19. 19
  20. 20

    Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens by Daly, K., Koch, J., Respaldiza, N., de la Horra, C., Montes-Cano, M.A., Medrano, F.J., Varela, J.M., Calderon, E.J., Walzer, P.D.

    Published in Clinical microbiology and infection (01-10-2009)
    “…The use of recombinant fragments of the major surface glycoprotein (Msg) of Pneumocystis jirovecii has proven useful for studying serological immune responses…”
    Get full text
    Journal Article